Articles by Roger Paredes

Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes

Pérez-Santiago, Josué; Ouchi, Dan; Urrea, Victor; More

AIDS. 30(15):2275-2287, September 24th, 2016.

Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing

Casadellà, Maria; Noguera-Julian, Marc; Sunpath, Henry; More

AIDS. 30(7):1137-1140, April 24th, 2016.

Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers

Coll, Josep; Moltó, José; Boix, Jaume; More

AIDS. 29(16):2149-2154, October 23rd, 2015.

Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced disease

Casadellà, Maria; Manzardo, Christian; Noguera-Julian, Marc; More

AIDS. 29(12):1493-1504, July 31st, 2015.

HIV resistance testing and detected drug resistance in Europe

Schultze, Anna; Phillips, Andrew N.; Paredes, Roger; More

AIDS. 29(11):1379-1389, July 17th, 2015.

Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy

Blanco, José L.; Montaner, Julio S.G.; Marconi, Vincent C.; More

AIDS. 28(17):2531-2539, November 13th, 2014.

Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progression

Dalmau, Judith; Rotger, Margalida; Erkizia, Itziar; More

AIDS. 28(9):1261-1272, June 1st, 2014.

Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population

Rodger, Alison J.; Lodwick, Rebecca; Schechter, Mauro; More

AIDS. 27(6):973-979, March 27th, 2013.

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

Li, Jonathan Z.; Paredes, Roger; Ribaudo, Heather J.; More

AIDS. 26(2):185-192, January 14th, 2012.

Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients

Ruiz, Lidia; Paredes, Roger; Gómez, Guadalupe; More

AIDS. 21(2):169-178, January 11th, 2007.

Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load

Negredo, Eugenia; Moltó, José; Burger, David; More

AIDS. 18(3):459-463, February 20th, 2004.

Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine

Negredo, Eugenia; Ribalta, Josep; Paredes, Roger; More

AIDS. 16(10):1383-1389, July 5th, 2002.

HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection

Ruiz, Lidia; Carcelain, Guislaine; Martínez-Picado, Javier; More

AIDS. 15(9):F19-F27, June 15th, 2001.